Subject of Possible Rule Making: New WAC 182-52-0100 Prescription drug affordability board—Upper payment limits; other related rules as appropriate.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: To implement the prescription drug affordability board (board) methodology for setting upper payment limits for prescription drugs the board has determined have led, or will lead to, excess costs based on its affordability review as required in RCW 70.405.050. During this review, the health care authority (agency) may identify additional related changes that improve clarity or update policy.

Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Not applicable.

Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Valerie Freudenstein, Rule-making Questions, P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-5128, fax 360-586-9727, telecommunication relay services (TRS) 711, email valerie.freudenstein@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking; or Simon Borumand, Program Questions, P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-1044, fax 360-586-9727, TRS 711, email simon.borumand@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking.